View More Recent Stories

Jun 16, 2025 04:19AM Citizens JMP Reiterates Market Outperform Rating on Kalvista Pharmaceuticals Inc (KALV)

Jun 13, 2025 04:06PM KalVista Pharmaceuticals (KALV) Announces FDA Will Not Meet PDUFA Goal Date for Sebetralstat

Apr 23, 2025 04:20AM Citizens JMP Reiterates Market Outperform Rating on Kalvista Pharmaceuticals Inc (KALV)

Apr 8, 2025 06:31AM KalVista Pharmaceuticals (KALV) Enters Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan

Mar 26, 2025 06:57AM Stifel Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)

Mar 26, 2025 06:49AM Cantor Fitzgerald Reiterates Overweight Rating on Kalvista Pharmaceuticals Inc (KALV)

Mar 26, 2025 04:11AM Citizens JMP Reiterates Market Outperform Rating on Kalvista Pharmaceuticals Inc (KALV)

Mar 25, 2025 07:02AM KalVista Pharmaceuticals (KALV) Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial

Mar 17, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)

Mar 13, 2025 04:36AM

Mar 12, 2025 07:00AM KalVista Pharmaceuticals (KALV) Misses Q3 EPS by 5c

Mar 3, 2025 07:05AM KalVista Pharmaceuticals (KALV) Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting

Mar 3, 2025 04:46AM Citizens JMP Reiterates Market Outperform Rating on Kalvista Pharmaceuticals Inc (KALV)

Feb 18, 2025 04:15AM JMP Securities Reiterates Market Outperform Rating on Kalvista Pharmaceuticals Inc (KALV)

Jan 31, 2025 05:11AM JMP Securities Reiterates Market Outperform Rating on Kalvista Pharmaceuticals Inc (KALV)

Jan 31, 2025 03:26AM JMP Securities Starts Kalvista Pharmaceuticals Inc (KALV) at Market Outperform

Jan 21, 2025 07:01AM KalVista Pharmaceuticals (KALV) Announces Orphan Drug Designation and NDA Submission for Sebetralstat in Japan for Hereditary Angioedema

Jan 7, 2025 05:32AM TD Cowen Starts Kalvista Pharmaceuticals Inc (KALV) at Buy

Dec 18, 2024 06:33AM BofA Securities Starts Kalvista Pharmaceuticals Inc (KALV) at Buy

Dec 16, 2024 07:01AM KalVista Pharmaceuticals (KALV) Appoints Jeb Ledell as COO

Dec 6, 2024 06:46AM H.C. Wainwright Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)

Dec 5, 2024 06:35AM KalVista Pharmaceuticals (KALV) Tops Q2 EPS by 2c

Nov 26, 2024 07:00AM KalVista Pharmaceuticals (KALV) Appoints Laurence Reid to its Board

Nov 5, 2024 07:13AM Kalvista Pharmaceuticals Inc (KALV) PT Lowered to $28 at Needham

Nov 4, 2024 07:06AM KalVista Pharmaceuticals (KALV) Prices 5.5M Share Offering at $10/sh

Nov 4, 2024 07:04AM KalVista Pharmaceuticals (KALV) Enters into Non-Dilutive Synthetic Royalty Financing with DRI Healthcare Trust

Oct 28, 2024 06:31AM KalVista Pharmaceuticals (KALV) Presents New Sebetralstat Data

Oct 7, 2024 06:35AM H.C. Wainwright Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)

Oct 4, 2024 12:30PM KalVista Pharmaceuticals (KALV) Presents Sebetralstat Data

Sep 30, 2024 06:30AM KalVista Pharmaceuticals (KALV) Submits Additional Marketing Authorization Applications for Sebetralstat for the Oral On-Demand Treatment of Hereditary Angioedema

Sep 27, 2024 07:04AM Jones Trading Starts Kalvista Pharmaceuticals Inc (KALV) at Buy

Sep 10, 2024 06:30AM KalVista (KALV) Appoints Brian Piekos as CFO

Sep 6, 2024 06:54AM H.C. Wainwright Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)

Sep 6, 2024 06:35AM Leerink Partners Reiterates Outperform Rating on Kalvista Pharmaceuticals Inc (KALV)

Sep 6, 2024 06:30AM KalVista Pharmaceuticals (KALV) Presents Sebetralstat Data

Sep 5, 2024 06:31AM KalVista Pharmaceuticals (KALV) Tops Q1 EPS by 3c

Sep 3, 2024 06:31AM KalVista Pharmaceuticals (KALV) Announces FDA Acceptance of NDA for Sebetralstat

Aug 15, 2024 06:32AM KalVista Pharmaceuticals (KALV) Announces Validation of Marketing Authorization Application by the EMA for Sebetralstat

Jul 15, 2024 08:27AM H.C. Wainwright Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)

Jul 11, 2024 04:52PM KalVista Pharmaceuticals (KALV) Files $300M Mixed Shelf

Jun 27, 2024 06:31AM KalVista Pharmaceuticals (KALV) Initiates KONFIDENT-KID Trial

Jun 18, 2024 06:31AM KalVista Pharmaceuticals (KALV) Submits NDA to FDA for Sebetralstat

View More Recent Stories